165 related articles for article (PubMed ID: 2208382)
21. In vivo and in vitro release of indomethacin from water-soluble and fatty base suppositories.
Furuno K; Gomita Y; Yoshida T; Oishi R; Saeki K; Araki Y
Acta Med Okayama; 1992 Aug; 46(4):223-31. PubMed ID: 1442146
[TBL] [Abstract][Full Text] [Related]
22. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
[TBL] [Abstract][Full Text] [Related]
23. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.
Kanke M; Tanabe E; Katayama H; Koda Y; Yoshitomi H
Biol Pharm Bull; 1995 Aug; 18(8):1154-8. PubMed ID: 8535416
[TBL] [Abstract][Full Text] [Related]
24. The release of isoconazole nitrate from different suppository bases: in-vivo release of drug labelled with 99mTc in rabbits.
Asikoglu M; Ertan G; Ercan MT; Duman Y
J Pharm Pharmacol; 1995 Sep; 47(9):717-20. PubMed ID: 8583381
[TBL] [Abstract][Full Text] [Related]
25. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
[TBL] [Abstract][Full Text] [Related]
26. Release and rectal absorption of ethosuximide from suppositories in rabbits.
Ghazy FS; Mohamed MS; Kassem AA; Elhoseiny BM
Pharmazie; 1988 Jul; 43(7):484-5. PubMed ID: 3222279
[TBL] [Abstract][Full Text] [Related]
27. Influence of storage temperature on indomethacin release from fatty-base suppositories in vitro and in vivo.
Yoshida T; Itoh Y; Gomita Y; Oishi R
Acta Med Okayama; 1991 Feb; 45(1):37-42. PubMed ID: 2063694
[TBL] [Abstract][Full Text] [Related]
28. Rectal absorption of metronidazole from polyethylene glycol suppositories.
Vromans H; Moolenaar F; Visser J; Meijer DK
Pharm Weekbl Sci; 1984 Feb; 6(1):18-20. PubMed ID: 6709483
[TBL] [Abstract][Full Text] [Related]
29. Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories.
Chicco D; Grabnar I; Skerjanec A; Vojnovic D; Maurich V; Realdon N; Ragazzi E; Belic A; Karba R; Mrhar A
Int J Pharm; 1999 Nov; 189(2):147-60. PubMed ID: 10536243
[TBL] [Abstract][Full Text] [Related]
30. Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery.
Miyazaki S; Oda M; Takada M; Attwood D
Biol Pharm Bull; 1995 Aug; 18(8):1151-3. PubMed ID: 8535415
[TBL] [Abstract][Full Text] [Related]
31. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
Maity S; Sa B; Bandyopadhyay AK
Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
[TBL] [Abstract][Full Text] [Related]
33. Studies on sustained-release suppositories. II. Evaluation of polymer electrolyte containing acidic groups for prolonged rectal absorption of bacampicillin in rabbits.
Kawashima S; Sugimura M; Noguchi T; Fujiwara H
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1899-903. PubMed ID: 2805169
[TBL] [Abstract][Full Text] [Related]
34. In vitro-in vivo evaluation of in situ gelling and thermosensitive ketoprofen liquid suppositories.
Ozgüney I; Kardhiqi A; Yıldız G; Ertan G
Eur J Drug Metab Pharmacokinet; 2014 Dec; 39(4):283-91. PubMed ID: 24096820
[TBL] [Abstract][Full Text] [Related]
35. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
36. [Sustained-release progesterone vaginal suppositories 3-development and clinical feasibility testing].
Nakayama A; Yamaguchi N; Ohno Y; Miyata C; Kondo H; Sunada H; Okamoto H
Yakugaku Zasshi; 2013; 133(6):727-36. PubMed ID: 23728096
[TBL] [Abstract][Full Text] [Related]
37. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery.
Miyazaki S; Suisha F; Kawasaki N; Shirakawa M; Yamatoya K; Attwood D
J Control Release; 1998 Dec; 56(1-3):75-83. PubMed ID: 9801431
[TBL] [Abstract][Full Text] [Related]
38. The in Vitro Release of Indomethacin from Suppositories: Effects of Bases and Comparison of Different Dissolution Methods.
Mori K; Hori S; Kawata T; Kogure S; Matsumoto K; Hasegawa T; Akimoto M
Chem Pharm Bull (Tokyo); 2017; 65(7):674-677. PubMed ID: 28674341
[TBL] [Abstract][Full Text] [Related]
39. Availability of oxyphenbutazone from different suppository formulations.
Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
[TBL] [Abstract][Full Text] [Related]
40. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
